S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?

Outset Medical (OM) Stock Price, News & Analysis

$2.22
+0.02 (+0.91%)
(As of 03/28/2024 ET)
Today's Range
$2.19
$2.36
50-Day Range
$1.99
$3.87
52-Week Range
$1.98
$24.13
Volume
485,148 shs
Average Volume
1.25 million shs
Market Capitalization
$112.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.13

Outset Medical MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
130.9% Upside
$5.13 Price Target
Short Interest
Bearish
16.87% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$653,545 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.28) to ($2.23) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.55 out of 5 stars

Medical Sector

748th out of 938 stocks

Electromedical Equipment Industry

13th out of 19 stocks

OM stock logo

About Outset Medical Stock (NASDAQ:OM)

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

OM Stock Price History

OM Stock News Headlines

Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Why Dialysis Stocks Are up Today
the most reliable asset on earth is making a comeback
Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.
Q4 2023 Outset Medical Inc Earnings Call
Outset Medical Q4 2023 Earnings Preview
OM Mar 2024 4.000 put
Outset Medical Inc (OM)
OM May 2024 10.000 call
OM Feb 2024 10.000 put
5 Analysts Have This to Say About Outset Medical
See More Headlines
Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/21/2024
Today
3/29/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Fax
N/A
Employees
480
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.13
High Stock Price Target
$6.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+130.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$-172,800,000.00
Net Margins
-132.54%
Pretax Margin
-132.14%

Debt

Sales & Book Value

Annual Sales
$130.38 million
Book Value
$2.45 per share

Miscellaneous

Free Float
48,637,000
Market Cap
$112.13 million
Optionable
Not Optionable
Beta
2.04
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

OM Stock Analysis - Frequently Asked Questions

Should I buy or sell Outset Medical stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" OM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OM, but not buy additional shares or sell existing shares.
View OM analyst ratings
or view top-rated stocks.

What is Outset Medical's stock price target for 2024?

5 equities research analysts have issued twelve-month target prices for Outset Medical's stock. Their OM share price targets range from $3.00 to $6.00. On average, they predict the company's stock price to reach $5.13 in the next twelve months. This suggests a possible upside of 130.9% from the stock's current price.
View analysts price targets for OM
or view top-rated stocks among Wall Street analysts.

How have OM shares performed in 2024?

Outset Medical's stock was trading at $5.41 at the beginning of 2024. Since then, OM stock has decreased by 59.0% and is now trading at $2.22.
View the best growth stocks for 2024 here
.

When is Outset Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our OM earnings forecast
.

How were Outset Medical's earnings last quarter?

Outset Medical, Inc. (NASDAQ:OM) issued its quarterly earnings results on Wednesday, February, 21st. The company reported ($0.77) earnings per share for the quarter, missing analysts' consensus estimates of ($0.74) by $0.03. The business earned $30.51 million during the quarter, compared to analyst estimates of $30.40 million. Outset Medical had a negative trailing twelve-month return on equity of 102.50% and a negative net margin of 132.54%.

What guidance has Outset Medical issued on next quarter's earnings?

Outset Medical updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $145.0 million-$153.0 million, compared to the consensus revenue estimate of $148.8 million.

When did Outset Medical IPO?

Outset Medical (OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Who are Outset Medical's major shareholders?

Outset Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (7.85%), Vanguard Group Inc. (7.80%), Bellevue Group AG (3.51%), Mubadala Investment Co PJSC (2.85%), Assenagon Asset Management S.A. (2.03%) and PFM Health Sciences LP (1.99%). Insiders that own company stock include D Keith Grossman, James F Hinrichs, James F Hinrichs, Jean-Olivier Racine, John L Brottem, John L Brottem, Leslie Trigg, Marc Nash, Martin Vazquez, Nabeel Ahmed, Rebecca Chambers, Stacey L Porter, Steven S Williamson and Warburg Pincus Llc.
View institutional ownership trends
.

How do I buy shares of Outset Medical?

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OM) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners